Resources

July 28, 2020
Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial

Inflammation in the case Covid-19: New study provides evidence of efficacy of CBD

Researchers never tire of looking for new approaches to the therapy of Covid-19. The majority of corona infections – the cause of Covid-19 – are mild. However, a considerable number of patients require intensive medical care and, in extreme cases, even ventilation.

Publish date: July 2, 2020
Two new studies offer positive news about medical cannabis, suggesting that marijuana products improve physical and cognitive symptoms, boost quality of life, and rarely produce signs of problematic use.

NIH

Century Label

THCV Hemp Oils

THCV is a cannabinoid and is known as the “sports car” of cannabinoids. Like CBD and THC, this means that it works with the human endocannabinoid system (ECS). Our ECS helps regulate our physical and mental well-being, influencing how we experience stress and anxiety, sleep, eat, and even our hormone levels.

Although THCV may sound like THC, its effects are quite the opposite. It is not psycho-active. According to several studies, it has been shown to suppress appetite, which may aid weight loss. It has also been shown to up-regulate energy metabolism, resulting in a motivated, alert, and energized feeling of euphoria, along with providing focus. For this reason, it is often recommended for daytime or any time when functionality is essential.

THCV relieves stress and research shows it can help to reduce or even prevent anxiety and panic attacks. For this reason, it plays an important role in the treatment of post-traumatic-stress-disorder (PTSD). It is also neuroprotective, so it is ideal for treating conditions such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis.

Scroll to top